Methylprednisolone in acute spinal cord injury: a tarnished standard.
Miller
Sanford M
SM
NYU School of Medicine and Bellevue Hospital Center, NY, USA. Sanford.miller@med.nyu.edu
D000208:Acute Disease; D000818:Animals; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008775:Methylprednisolone / Q000009:adverse effects / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D020127:Recovery of Function / Q000187:drug effects; D012107:Research Design / Q000592:standards*; D013119:Spinal Cord Injuries / Q000188:drug therapy*; D013223:Statistics as Topic / Q000379:methods / Q000592:standards*; D014481:United States
D018696:Neuroprotective Agents; D008775:Methylprednisolone